Glaxosmithkline Mercury Limited

Active07004253 Private limited company
Incorporated
28 August 2009 (17 years)
Industry
Activities of head offices (70100)
Owned by
Accounts type
Full
Region
Greater London
Address
79 New Oxford Street
London
WC1A 1DG

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
30 April 2027
Last conf. stmt
16 April 2026

Officers 4 active

Officer details are public data from the Companies House register.

Officer history (6 former)
11 January 2022
Appointed Guittard, Laura as Director
11 January 2022
Resigned Lynch, Ciara Martha as Director
2 March 2020
Resigned Borger, James as Director
2 March 2020
Appointed Lynch, Ciara Martha as Director
3 April 2019
Resigned Burns, Alan George as Director
25 February 2019
Appointed Borger, James as Director
13 February 2019
Resigned Dubianskij, Oleg as Director
31 January 2017
Appointed Dubianskij, Oleg as Director
14 December 2012
Resigned Davies, Derek as Director
3 December 2012
Appointed Burns, Alan George as Director
20 October 2010
Resigned Grist, Ashley Alexander as Director
16 August 2010
Appointed Davies, Derek as Director
28 August 2009
Appointed Glaxo Group Limited as Corporate Director
28 August 2009
Appointed Edinburgh Pharmaceutical Industries Limited as Corporate Director
28 August 2009
Appointed Whyte, Victoria Anne as Secretary
28 August 2009
Appointed Grist, Ashley Alexander as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. 3888792

Group structure 22 shown

Ownership group derived from the Companies House PSC register

British Pharma Group Limited Holds 25–50% of voting rights
Glaxosmithkline Holdings Limited Owns 75–100% of shares
Glaxosmithkline Finance PLC Owns 75–100% of shares
Glaxo Group Limited Owns 75–100% of shares
Glaxosmithkline Ihc Limited Owns 75–100% of shares
GSK Finance (No 2) Limited Owns 75–100% of shares
Setfirst Limited Owns 75–100% of shares
Smithkline Beecham Limited Owns 75–100% of shares
Wellcome Limited Owns 75–100% of shares
Glaxosmithkline Mercury Limited This company Owns 75–100% of shares
Viiv Healthcare Limited Owns 75–100% of shares
Viiv Healthcare Finance 2 Limited Owns 75–100% of shares
Viiv Healthcare Overseas Limited Owns 75–100% of shares
Viiv Healthcare UK (No.4) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.5) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.6) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.7) Limited Owns 75–100% of shares
Viiv Healthcare UK Limited Owns 75–100% of shares
Glaxosmithkline Services Unlimited Owns 75–100% of shares

Filings 65

DateDescriptionMade Up ToPagesPDF
30 May 2026Full accounts31 December 2025
16 April 2026Confirmation statement with no updates16 April 2026
30 July 2025Confirmation statement with no updates30 July 2025
28 July 2025Full accounts31 December 2024
23 September 2024Secretary's details changed
Show all 65 filings

Some other companies at this address

Other companies in this industry

By trade and location

New companies in London →

Explore the largest companies

Largest companies in London, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?